Loading clinical trials...
Loading clinical trials...
Impact of an Adapted Physical Activity Program on Event-free Survival in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
Conditions
Interventions
Adapted physical activity
Locations
5
France
CHU Jean Minjoz
Besançon, France
Clinique Victor Hugo / Centre Jean Bernard
Le Mans, France
CHRU Nancy
Nancy, France
Hôpital Privé du Confluent
Nantes, France
CH Perpignan
Perpignan, France
Start Date
September 8, 2021
Primary Completion Date
August 1, 2025
Completion Date
February 1, 2029
Last Updated
October 8, 2021
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Weprom
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions